Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 35 studies | 43% ± 19% | |
astrocyte | 16 studies | 45% ± 21% | |
endothelial cell of lymphatic vessel | 14 studies | 53% ± 24% | |
ciliated cell | 14 studies | 36% ± 15% | |
microglial cell | 13 studies | 45% ± 15% | |
vein endothelial cell | 13 studies | 43% ± 29% | |
glutamatergic neuron | 11 studies | 41% ± 22% | |
macrophage | 11 studies | 30% ± 14% | |
oligodendrocyte | 11 studies | 34% ± 13% | |
oligodendrocyte precursor cell | 10 studies | 36% ± 14% | |
endothelial cell of vascular tree | 10 studies | 34% ± 22% | |
GABAergic neuron | 9 studies | 47% ± 21% | |
epithelial cell | 9 studies | 34% ± 16% | |
basal cell | 9 studies | 35% ± 16% | |
club cell | 8 studies | 35% ± 17% | |
capillary endothelial cell | 8 studies | 32% ± 18% | |
adipocyte | 8 studies | 34% ± 10% | |
endothelial cell of artery | 8 studies | 38% ± 23% | |
pericyte | 7 studies | 25% ± 13% | |
fibroblast | 7 studies | 27% ± 7% | |
respiratory goblet cell | 6 studies | 47% ± 23% | |
interneuron | 6 studies | 53% ± 19% | |
retina horizontal cell | 6 studies | 48% ± 25% | |
type II pneumocyte | 6 studies | 47% ± 15% | |
smooth muscle cell | 5 studies | 35% ± 20% | |
neuron | 5 studies | 50% ± 22% | |
dendritic cell | 5 studies | 19% ± 0% | |
lymphocyte | 5 studies | 26% ± 11% | |
monocyte | 5 studies | 31% ± 6% | |
type I pneumocyte | 5 studies | 29% ± 9% | |
cholangiocyte | 4 studies | 58% ± 21% | |
hepatocyte | 4 studies | 72% ± 24% | |
granule cell | 4 studies | 28% ± 3% | |
retinal bipolar neuron | 4 studies | 28% ± 12% | |
cardiac muscle cell | 4 studies | 22% ± 4% | |
retinal ganglion cell | 4 studies | 42% ± 23% | |
T cell | 4 studies | 28% ± 7% | |
ionocyte | 3 studies | 35% ± 8% | |
secretory cell | 3 studies | 25% ± 1% | |
endothelial cell of sinusoid | 3 studies | 43% ± 11% | |
GABAergic interneuron | 3 studies | 45% ± 18% | |
CD4-positive, alpha-beta T cell | 3 studies | 23% ± 4% | |
CD8-positive, alpha-beta T cell | 3 studies | 18% ± 2% | |
endocardial cell | 3 studies | 50% ± 24% | |
mesothelial cell | 3 studies | 33% ± 11% | |
GABAergic amacrine cell | 3 studies | 41% ± 13% | |
Mueller cell | 3 studies | 34% ± 7% | |
ON-bipolar cell | 3 studies | 46% ± 20% | |
amacrine cell | 3 studies | 34% ± 8% | |
glycinergic amacrine cell | 3 studies | 29% ± 9% | |
retinal rod cell | 3 studies | 21% ± 4% | |
myeloid cell | 3 studies | 24% ± 6% | |
abnormal cell | 3 studies | 34% ± 22% | |
ependymal cell | 3 studies | 30% ± 13% | |
alveolar macrophage | 3 studies | 25% ± 8% | |
natural killer cell | 3 studies | 23% ± 4% | |
transit amplifying cell | 3 studies | 31% ± 18% | |
brush cell | 3 studies | 31% ± 10% | |
mast cell | 3 studies | 25% ± 5% | |
mucus secreting cell | 3 studies | 54% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 5375.02 | 245 / 245 | 100% | 53.92 | 500 / 502 |
stomach | 100% | 5219.03 | 359 / 359 | 99% | 36.52 | 283 / 286 |
intestine | 100% | 3567.90 | 964 / 966 | 98% | 30.69 | 515 / 527 |
pancreas | 100% | 3683.94 | 327 / 328 | 98% | 21.85 | 174 / 178 |
thymus | 100% | 9045.97 | 653 / 653 | 96% | 24.87 | 579 / 605 |
lung | 100% | 9665.32 | 578 / 578 | 94% | 21.89 | 1082 / 1155 |
bladder | 100% | 3921.33 | 21 / 21 | 92% | 26.82 | 466 / 504 |
esophagus | 100% | 2933.84 | 1444 / 1445 | 92% | 28.19 | 169 / 183 |
kidney | 100% | 3297.78 | 89 / 89 | 91% | 15.76 | 822 / 901 |
liver | 100% | 5531.50 | 226 / 226 | 91% | 16.42 | 370 / 406 |
breast | 100% | 5986.37 | 459 / 459 | 89% | 17.55 | 992 / 1118 |
ovary | 99% | 2730.63 | 179 / 180 | 86% | 12.01 | 368 / 430 |
uterus | 100% | 3859.32 | 170 / 170 | 83% | 13.74 | 381 / 459 |
brain | 80% | 1467.17 | 2124 / 2642 | 84% | 8.25 | 593 / 705 |
skin | 86% | 4487.95 | 1562 / 1809 | 67% | 6.08 | 316 / 472 |
adrenal gland | 99% | 2355.50 | 255 / 258 | 39% | 3.12 | 89 / 230 |
adipose | 100% | 6100.25 | 1204 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 6534.01 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2993.95 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 11.49 | 1 / 1 |
peripheral blood | 95% | 5258.95 | 882 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 95% | 1961.46 | 1263 / 1335 | 0% | 0 | 0 / 0 |
heart | 93% | 1843.66 | 804 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 82% | 12.81 | 37 / 45 |
lymph node | 0% | 0 | 0 / 0 | 48% | 3.80 | 14 / 29 |
eye | 0% | 0 | 0 / 0 | 26% | 1.82 | 21 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0051056 | Biological process | regulation of small GTPase mediated signal transduction |
GO_0090630 | Biological process | activation of GTPase activity |
GO_0005615 | Cellular component | extracellular space |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0005515 | Molecular function | protein binding |
GO_0005096 | Molecular function | GTPase activator activity |
Gene name | RALGAPA2 |
Protein name | Ral GTPase activating protein catalytic subunit alpha 2 Ral GTPase-activating protein subunit alpha-2 (250 kDa substrate of Akt) (AS250) (p220) |
Synonyms | C20orf74 KIAA1272 |
Description | FUNCTION: Catalytic subunit of the heterodimeric RalGAP2 complex which acts as a GTPase activator for the Ras-like small GTPases RALA and RALB. . |
Accessions | ENST00000202677.12 [Q2PPJ7-1] ENST00000430436.5 A0A3B3IS41 H7BZA8 ENST00000427175.2 Q2PPJ7 H7C1F9 ENST00000495793.2 |